Uric Acid Protects against Focal Cerebral Ischemia/Reperfusion-Induced Oxidative Stress via Activating Nrf2 and Regulating Neurotrophic Factor Expression
doi: 10.1210/jcem.80.11.7593445 15 AstrmCPedersenSALindholmJ
Mechanistically, alterations in gut microbial metabolites such as SCFAs could affect the integrity of the BBB, induce systemic endotoxemia, and activate microglia so as to impact disease progression
Summary: retatrutide availability Retatrutide is not commercially available in any country as of April 2026 Expected FDA approval: 2027-2028, with commercial launch following 2-4 months later International rollout: UK and Canada 2027-2028, EU 2028-2029, Australia 2028-2030 Current access: Clinical trials (free), compounding pharmacies ($200-500/mo), research peptides ($150-500/mo) Post-approval expectations: Supply shortages likely for 12-24 months
S., Egerod, K
GLP-1 drugs are diabetes medications with weight-loss effects prescribed to those struggling with obesity and Type 2 diabetes